Rare diseases
Investigational molecules
Locations
Back to France263 clinical trials in Avignon, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FrancePhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
FranceStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
FranceStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
FranceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
FranceA study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on head and neck cancers, gastric cancer, and pancreatic adenocarcinoma. Studies evaluate novel combination therapies and targeted treatments to improve patient outcomes.
Multiple trials investigating breakthrough treatments for locally advanced and metastatic diseases.
Groundbreaking research in multiple myeloma and lymphoma treatments, exploring novel therapeutic approaches and combination strategies.
Focus on improving treatment outcomes for both newly diagnosed and relapsed patients.
Comprehensive studies of non-small cell lung cancer treatments, investigating immunotherapy combinations and personalized treatment approaches.
Emphasis on developing more effective and tolerable treatment regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
